About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,491 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,491 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 701-720 of 7,491 trials

UnknownMR-targeted vs. Random TRUS-guided Prostate BiopsyTo compare prostate cancer (PCa) detection rate of magnetic resonance (MR)-targeted biopsy and transrectal ultrasound (TRUS)-guided biopsy in patients with high PSA values and at…NCT02678481·Candiolo, Turin CompletedInnovative Planning and Guidance System for Prostate Focal BrachytherapyA key feature of low-dose brachytherapy is that irradiation affects only a local area around the inserted radiation sources.NCT03160365·Brest

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedFeasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate BrachytherapyThis study will investigate the efficacy of Degarelix, a Luteinizing Hormone Releasing Hormone (LHRH) antagonist, to reduce prostate volume prior to permanent seed prostate…NCT01446991·Abbottsford, British Columbia and 2 others

CompletedEvaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate CancerTaxotere® can induce nails changes like dyschromia, hematoma, lines of Beau-Reil (signing the stop of the epithelial proliferation), abscess, or pain.NCT00925418·Marseille

CompletedStudy of Health Promotion in Patients With Early-Stage Breast or Prostate CancerRATIONALE: Telephone counseling by a nutritionist and a personal trainer may improve physical function and quality of life in patients who have early-stage breast cancer or…NCT00037024·Durham, North Carolina

CompletedA Pharmacokinetic Study of Genistein, a Tyrosine Kinase InhibitorGenistein is a natural product found in soy beans; its consumption has been associated with a low incidence of metastatic prostate cancer.NCT00001696·Bethesda, Maryland

CompletedTriptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, such as triptorelin and flutamide, may stop the adrenal glands from making androgens.NCT00104741·Alès and 30 others

RecruitingSafety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)A single institution with a single group, a phase II study, low- and medium-risk studies performed after biodegradable substance injection prostate cancer dosage increase.NCT06461819·Seoul

CompletedStudy of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)This is a Phase II study to test the efficacy of exogenously administered GM-CSF in prostate cancer patients who have failed definitive local therapy, and have only serologic…NCT00678054·San Francisco, California

CompletedStreaming Web-based Exercise At Home: A Pilot StudyThis is a single-arm pilot study to evaluate the use of web-based video conferencing as a method of exercise training delivery.NCT04282967·Los Angeles, California

Not yet recruitingCarboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate CancerThe current standard of patients with de novo metastatic hormone sensitive prostate cancer (mHSPC) is to offer androgen deprivation therapy (ADT) with androgen receptor pathway…NCT07591467·Bordeaux and 4 others

CompletedThe Effects of Pilates in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary IncontinenceThe purpose of this study is to compare the efficacy between a Pilates exercise program and a Pelvic Floor Muscle Training (PFMT) protocol combined with anal electrical…NCT02645136

Active not recruitingRisk Factors, Incidence, and Progression of Lymphedema Among Men With Prostate Cancer. The AWARE CohortThe goal of this observational study is to examine the development and impact of lymphedema in men treated for prostate cancer.NCT07607431·Copenhagen and 2 others

CompletedPhase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate CancerThe VIABLE study sought to confirm the hypothesis that the combination of docetaxel with DCVAC/PCa followed by a maintenance therapy with DCVAC/PCa would improve overall survival…NCT02111577·Mobile, Alabama and 176 others

CompletedNon-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer PatientsThe purpose of this study is to establish an expert consensus recommendations on managing patients with mHSPC in South Korea, and to provide clinicians with a comprehensive guide…NCT06452212·Seoul

CompletedHigh Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy ImplantationThe purpose of this study is to establish the correct scanning parameters for obtaining good quality 3 Tesla (3T) magnetic resonance spectroscopy images (MRSI) of the prostate…NCT00126854·Edmonton, Alberta

Approved for marketingEarly Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorMerus is providing single patient/named access to the HER2/HER3 bispecific antibody, MCLA-128, to patients with advanced NRG1-fusion positive solid tumor under this early access…NCT04100694

Active not recruitingThe IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte CancerThe IMPACT study is an international targeted prostate screening study of men at increased prostate cancer risk due to the presence of known pathogenic mutations in BRCA1 and…NCT00261456·Sutton, Surrey

Not yet recruitingEvaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.Patients undergo three diagnostic PET scans: 18F-FDG PET scan / 18F-Choline PET scan and 68Ga-PSMA PET scan.NCT06136377

CompletedPertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate CancerThis phase II trial tests how well pertuzumab, trastuzumab, hyaluronidase-zzxf and enzalutamide works in treating patients with castration-resistant prostate cancer that has…NCT05730712·Scottsdale, Arizona and 2 others

PreviousPage 36 of 375Next